Tms. Wolever et al., PROPIONATE INHIBITS INCORPORATION OF COLONIC [1,2-C-13]ACETATE INTO PLASMA-LIPIDS IN HUMANS, The American journal of clinical nutrition, 61(6), 1995, pp. 1241-1247
Acetate and propionate, produced during colonic fermentation of unabso
rbed carbohydrate, may influence systemic lipid metabolism. As a preli
minary study to see whether colonic acetate is incorporated into plasm
a lipids and whether propionate inhibits this process, 5 healthy males
were studied after fasting overnight. They were given, in random orde
r, 12.5 mmol (1.05 g) [1,2-C-13] sodium acetate by intravenous or rect
al infusion, and the rectal infusion was given with or without 6 mmol
(0.58 g) sodium propionate. Two hours after rectal acetate, C-13 recov
eries in plasma cholesterol (0.59 +/- 0.22%) and triglycerides (1.24 /- 0.69%) were significantly greater than after intravenous acetate (0
.09 +/- 0.12% and 0.29 +/- 0.18%, respectively). Addition of propionat
e reduced C-13 recovery in triglycerides (0.19 +/- 0.06%, P = 0.024) c
ompared with rectal acetate alone, but the effect on cholesterol (0.26
+/- 0.05%) was not significant. These data suggest that incorporation
of colonic acetate into plasma triglycerides is inhibited by propiona
te. Further studies are required to quantify the effects of colonic ac
etate and propionate on lipid synthesis.